Being tested
Clemastine: repair myelin in relapsing and progressive MS
relapsing and progressive MS · Remyelination / oligodendrocyte repair
Trials are running now and no controlled trial has a readable result yet.
- Trials
- 1
- Running now
- 1
- Controlled phase 2/3 trials
- 0
- People in controlled trials
- 0
How the verdict was reached
No result yet
| Trial | Phase | Participants | Started | Result | Counted |
|---|---|---|---|---|---|
| ReVIVE | Phase1|phase2 | 74 | 2023 | Still running | Not counted: tested as the comparator |
Counted: 0. Will count later: 0. Not counted: 1.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- Oct 2026First listed as Being tested
Related hypotheses
- Clemastine: repair myelin in optic neuritis
- Clemastine: repair myelin in relapsing MS
- Clemastine: repair myelin in MS (type not specified)
- Gsk239512: repair myelin in relapsing and progressive MS
- Elezanumab: slow disability worsening in relapsing and progressive MS
- Opicinumab: slow disability worsening in relapsing and progressive MS
- Gsk239512: reduce relapses and new lesions in relapsing and progressive MS
Assembled by software from public sources.